| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 4, 2025 | ABBOTT LABORATORIES | CEO | Sell | 17.5 | -31,651 | -6.56% | ✗ | $4.3M |
| Feb 5, 2025 | Feb 7, 2025 | ABBOTT LABORATORIES | CEO | Sell | 15.0 | -285,388 | -40.60% | ✗ | $37.4M |
| Sep 12, 2024 | Sep 13, 2024 | ABBOTT LABORATORIES | CEO | Sell | 15.0 | -141,679 | -25.34% | ✗ | $16.5M |
| Feb 29, 2024 | Mar 4, 2024 | ABBOTT LABORATORIES | CEO | Sell | 17.5 | -31,610 | -7.04% | ✗ | $3.8M |
| Feb 28, 2023 | Mar 2, 2023 | ABBOTT LABORATORIES | CEO | Sell | 17.5 | -30,742 | -7.51% | ✗ | $3.1M |
| Aug 25, 2022 | Aug 26, 2022 | ABBOTT LABORATORIES | CEO | Sell | 7.5 | -102,425 | -23.18% | ✓ | $10.8M |
| Feb 28, 2022 | Mar 2, 2022 | ABBOTT LABORATORIES | CEO | Sell | 17.5 | -26,579 | -7.26% | ✗ | $3.3M |
| Feb 26, 2021 | Mar 2, 2021 | ABBOTT LABORATORIES | CEO | Sell | 17.5 | -22,865 | -7.26% | ✗ | $2.8M |
| Feb 28, 2020 | Mar 3, 2020 | ABBOTT LABORATORIES | COO | Sell | 17.5 | -16,638 | -6.36% | ✗ | $1.3M |
| Feb 28, 2019 | Mar 4, 2019 | ABBOTT LABORATORIES | COO | Sell | 17.5 | -14,682 | -6.92% | ✗ | $1.1M |
| Jun 1, 2018 | Jun 5, 2018 | ABBOTT LABORATORIES | President | Sell | 51.3 | -299 | -0.18% | ✗ | $18.4K |
| Feb 28, 2018 | Mar 2, 2018 | ABBOTT LABORATORIES | President | Sell | 20.0 | -10,721 | -6.05% | ✗ | $649.2K |
| Jan 30, 2018 | Feb 1, 2018 | ABBOTT LABORATORIES | President | Sell | 10.0 | -40,802 | -23.56% | ✓ | $2.6M |
| Jan 30, 2018 | Feb 1, 2018 | ABBOTT LABORATORIES | President | Sell | 5.0 | -42,665 | -31.46% | ✓ | $2.7M |